Sell Aurobindo Pharma, price target Rs 440: Manas Jaiswal

The analyst suggested a stoploss at Rs 486 .

Shutterstock.com
Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 27559.62 Crore) operating in Pharmaceuticals sector.
Manas Jaiswal of manasjaiswal.com has a sell call on Aurobindo Pharma Ltd. with a target price of Rs 440.0 . The current price of Aurobindo Pharma Ltd. is Rs 454.3 . Manas Jaiswal recommended to keep a stoploss at Rs 486 .

Aurobindo Pharma Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 27559.62 Crore) operating in Pharmaceuticals sector.

Aurobindo Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11922.63 Crore to Sales Value (97.26 % of Total Sales), Export Incentives which contributed Rs 303.72 Crore to Sales Value (2.47 % of Total Sales), Sale of services which contributed Rs 16.07 Crore to Sales Value (0.13 % of Total Sales) and Scrap which contributed Rs 15.47 Crore to Sales Value (0.12 % of Total Sales)for the year ending 31-Mar-2019.


For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 5799.44 Crore, up 5.10 % from last quarter Sales of Rs 5518.27 Crore and up 12.06 % from last year same quarter Sales of Rs 5175.26 Crore Company has reported net profit after tax of Rs 705.95 Crore in latest quarter.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

Related Companies

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Sell Aurobindo Pharma, price target Rs 440: Manas Jaiswal
Text Size:AAA
Success
This article has been saved

*

+